Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of Clopidogrel on Terbogrel Pharmacodynamics
NCT02222987Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Feb 1999
- Primary completion
- Mar 1999
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of terbogrel in thrombosis (3 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Change in inhibition of platelet aggregation in platelet rich plasma (PRP), Change in thromboxane receptor occupancy (TRO) and 2 more. Started Feb 1999; status: completed.
02
Drugs
terbogrel
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT02222987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02222987.